North New Hyde Park, NY1 Active Studies

Psoriatic Arthritis Clinical Trials in North New Hyde Park, NY

Find 1 actively recruiting psoriatic arthritis clinical trials in North New Hyde Park, NY. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
60
Enrolling

Recruiting Psoriatic Arthritis Studies in North New Hyde Park

About Psoriatic Arthritis Clinical Trials in North New Hyde Park

Psoriatic arthritis is a form of inflammatory arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling. It can affect any joint and varies in severity. Treatment includes NSAIDs, DMARDs, biologics, and JAK inhibitors.

There are currently 1 psoriatic arthritis clinical trials recruiting participants in North New Hyde Park, NY. These studies are seeking a combined 60 participants. Research is being sponsored by Bristol-Myers Squibb. Clinical trial participation is free and participants receive study-related medical care at no cost.

Psoriatic Arthritis Clinical Trials in North New Hyde Park — FAQ

Are there psoriatic arthritis clinical trials in North New Hyde Park?

Yes, there are 1 psoriatic arthritis clinical trials currently recruiting in North New Hyde Park, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in North New Hyde Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the North New Hyde Park research site will contact you about next steps.

Are clinical trials in North New Hyde Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many North New Hyde Park studies also compensate for your time and travel.

What psoriatic arthritis treatments are being tested?

The 1 active trials in North New Hyde Park are testing new therapies including novel drugs, biologics, and treatment approaches for psoriatic arthritis.

Data updated March 2, 2026 from ClinicalTrials.gov